Ali Aleeza, Picado Omar, Mathew Prakash J, Ovadia Steven, Thaller Seth R
Herbert Wertheim College of Medicine; Florida International University, Miami, Florida, USA.
Division of Plastic and Reconstructive Surgery; DeWitt Daughtry Family Department of Surgery, University of Miami Leonard M. Miller School of Medicine, Miami, Florida, USA.
Aesthetic Plast Surg. 2023 Oct;47(5):1678-1682. doi: 10.1007/s00266-022-02972-x. Epub 2022 Jun 17.
Capsular contracture is the most common complication of breast augmentation and reconstruction. It occurs in up to 45% of patients and is theorized to occur secondary to an immune reaction. It can lead to pain, dissatisfaction with aesthetic outcomes, and reoperation. The gold standard for management is capsulectomy. Prior similar studies are limited by narrow inclusion criteria, single-surgeon analysis, small sample size, or univariate analysis. The goal of the following study is to prospectively identify possible risk factors for capsular contracture using a national database.
A retrospective review was conducted utilizing the National Surgical Quality Improvement Program (NSQIP) Database of prospectively collected data of patients undergoing periprosthetic and/or total capsulectomy for capsular contracture from 2013 to 2016. Odds ratios (OR) with 95% confidence intervals (CI) were calculated for variables using a multivariable binary logistic regression model.
A total of 6547 patients underwent reconstructive or augmentation mammaplasty with a prosthetic implant, out of which 2543 (39%) underwent capsulectomy. Capsular contracture was more likely in older (OR: 1.10, 95% CI: 1.09-1.10, p<.001), overweight (OR: 1.12, 95% CI: 1.10-1.13, p<.001), and cancer patients (OR: 7.71, 95% CI: 2.22-28.8, p=0.001). Wound infection was associated with capsulectomy (OR: 6.69, 95% CI: 1.74-25.8, p<.001).
These identified risk factors should be comprehensively addressed with patients during the informed consent process before breast augmentation or reconstruction with implants.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
包膜挛缩是隆乳术和乳房重建术最常见的并发症。高达45%的患者会出现这种情况,理论上其发生是继发于免疫反应。它可导致疼痛、对美学效果不满意以及再次手术。治疗的金标准是包膜切除术。先前的类似研究受到纳入标准狭窄、单术者分析、样本量小或单变量分析的限制。以下研究的目的是利用国家数据库前瞻性地确定包膜挛缩可能的风险因素。
利用国家外科质量改进计划(NSQIP)数据库进行回顾性研究,该数据库前瞻性收集了2013年至2016年因包膜挛缩接受假体周围和/或全包膜切除术患者的数据。使用多变量二元逻辑回归模型计算变量的比值比(OR)及95%置信区间(CI)。
共有6547例患者接受了假体植入的重建或隆乳术,其中2543例(39%)接受了包膜切除术。年龄较大(OR:1.10,95%CI:1.09 - 1.10,p <.001)、超重(OR:1.12,95%CI:1.10 - 1.13,p <.001)以及癌症患者(OR:7.71,95%CI:2.22 - 28.8,p = 0.001)发生包膜挛缩的可能性更高。伤口感染与包膜切除术相关(OR:6.69,95%CI:1.74 - 25.8,p <.001)。
在植入物隆乳或乳房重建术前的知情同意过程中,应与患者全面讨论这些已确定的风险因素。
证据级别III:本期刊要求作者为每篇文章指定证据级别。有关这些循证医学评级的完整描述,请参阅目录或在线作者指南www.springer.com/00266 。